CL Mobile Menu


Drug Offers Novel Approach for Airway Diseases

For patients with asthma or COPD, PL554 has the potential to both reverse bronchodilation and reduce inflammation more quickly and with fewer adverse effects.



The GOLD criteria for COPD assessment have not lived up to their promise. Internationally agreed standards seem to be the real deal.

© Nightman1965/

Undiagnosed lung disease in smokers, the impact of guidelines for community-acquired pneumonia in children, and climate change and asthma attacks make headlines in the respiratory news.

Obstructive, restrictive, or mixed airways disease? See what you know about asthma, COPD, and the test results used to diagnose each.

Respiratory disease is the main reason why patients visit primary care practices. This brief summary highlights the latest in research and patient care.

COPD challenges, asthma in children, smoking deaths—highlights of recent research findings in these key areas of respiratory disease.

Long-acting beta-agonists offer benefits in COPD. Not true for inhaled corticosteroids for most, it turns out.

There is emergent need to improve recognition and management of COPD in HIV-infected patients. Details here.


Subscribe to COPD on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.